Prasterone

DB01708ApprovedInvestigationalNutraceuticalSmall molecule

Prasterone is a steroid formulated as a vaginal insert indicated for the treatment of moderate to severe dyspareunia associated with menopausal vulvar and vaginal atrophy. Prasterone, also known as dehydroepiandrosterone (DHEA) is a major C19 steroid produced by the adrenal cortex.

Chemical structure of Prasterone
Mechanism
Curator reviewed
Primary indication
DHEA is taken as a supplement for a variety of unsubstantiated indications.Curator reviewed · 2 structured indications
Formula / weight
C19H28O2 · 288.4244 g/mol (avg)
First approval
Canada, 2023 · United States, 2017 · European Union, 2020
Also known as
Dehydroandrosterone · Dehydroepiandrosterone · Dehydroisoandrosterone · DHEA
Brand names
  • Intrarosa

Resolves to

Structure
InChIKeyFMGSKLZLMKYGDP-USOAJAOKSA-NSMILES[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C

What you can answer from here — as of September 12, 2026

10Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7TransportersSubstrate / inhibitor direction, not just membership
Listed above
701Drug interactionsStructured to mechanism, not free text
Sign in
77Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
9Marketed productsAcross 4 countries and 6 labellers
Sign in
3ATC codesIncluding every combination product, plus 35 drug categories
Sign in
46+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Prasterone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account